← Leaderboards
Richard E Zigmond
Case Western Reserve University
$14,345,843
Attributed
$17,740,554
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$17,740,554 · 10
By mechanism
R01$12,145,640 · 7
RF1$5,437,914 · 2
R56$157,000 · 1
Top collaborators
- Wen-Cheng Xiong4 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Henry J Kaminski$13,990,719
- Anita C Gilliam$2,181,316
- Kevin L Kilgore$17,814,943
- Ganesh K Kumar$2,610,441
- Brian Smith$4,207,113
Others in their field
Top investigators on “Nerve”
- Paul S. Aisen · Cognition Therapeutics, Inc.$113,855,136
- Reisa A. Sperling · Banner Health$83,018,714
- Randall J Bateman · Washington University$82,666,289
- Jose A Luchsinger · Columbia University Health Sciences$75,117,371
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$73,809,994
- Keith A. Johnson · Banner Health$69,867,152
Research focus
NerveGenesGene ExpressionLesionInjuryResponseNeuronsCellsNerve RegenerationAxotomyGrowthNatural RegenerationInjuredNeurogliaProteinsPeripheralSciatic NervePeripheral Nervous SystemPhenotypeIn Situ HybridizationPeripheral Nervous System DiseasesPlayGangliaDiabetes Mellitus
Grant awards (33)
LRP4 deficiency in Alzheimer's disease development$707,854
R01 · FY2024 · AG
Swedish APP mutation and NMJ decline in Alzheimer's disease$643,654
R01 · FY2024 · AG
Neuroinflammation in Wallerian Degeneration and Regeneration: Neutrophils Play a Primary Role as Phagocytes$485,474
R01 · FY2024 · NS · contact PI
Neuroinflammation in Wallerian Degeneration and Regeneration: Neutrophils Play a Primary Role as Phagocytes$500,390
R01 · FY2023 · NS · contact PI
Neuroinflammation in Wallerian Degeneration and Regeneration: Neutrophils Play a Primary Role as Phagocytes$500,292
R01 · FY2022 · NS · contact PI
Neuroinflammation in Wallerian Degeneration and Regeneration: Neutrophils Play a Primary Role as Phagocytes$500,193
R01 · FY2021 · NS · contact PI
LRP4 deficiency in Alzheimer's disease development$2,846,666
RF1 · FY2020 · AG
Swedish APP mutation and NMJ decline in Alzheimer's disease$2,591,248
RF1 · FY2020 · AG
Neuroinflammation in Wallerian Degeneration and Regeneration: Neutrophils Play a Primary Role as Phagocytes$506,071
R01 · FY2020 · NS · contact PI
Mechanisms underlying macrophage action in nerve regeneration and degeneration$473,095
R01 · FY2020 · NS · contact PI
Mechanisms underlying macrophage action in nerve regeneration and degeneration$568,173
R01 · FY2019 · NS · contact PI
Mechanisms underlying macrophage action in nerve regeneration and degeneration$568,173
R01 · FY2018 · NS · contact PI
Mechanisms underlying macrophage action in nerve regeneration and degeneration$473,095
R01 · FY2017 · NS · contact PI
Mechanisms underlying macrophage action in nerve regeneration and degeneration$87,155
R01 · FY2017 · NS · contact PI
Mechanisms underlying macrophage action in nerve regeneration and degeneration$473,095
R01 · FY2016 · NS · contact PI
gp130 Cytokines, Diabetic Autonomic Neuropathy, and Nerve Regeneration$376,442
R01 · FY2016 · DK · contact PI
gp130 Cytokines, Diabetic Autonomic Neuropathy, and Nerve Regeneration$376,442
R01 · FY2015 · DK · contact PI
gp130 Cytokines, Diabetic Autonomic Neuropathy, and Nerve Regeneration$376,442
R01 · FY2014 · DK · contact PI
gp130 Cytokines, Diabetic Autonomic Neuropathy, and Nerve Regeneration$396,939
R01 · FY2013 · DK · contact PI
gp130 Cytokines, Diabetic Autonomic Neuropathy, and Nerve Regeneration$157,000
R56 · FY2012 · DK · contact PI
Recovery of Function Following Neural Damage$310,860
R01 · FY2010 · NS · contact PI
Recovery of Function Following Neural Damage$314,000
R01 · FY2009 · NS · contact PI
Recovery of Function Following Neural Damage$314,000
R01 · FY2008 · NS · contact PI
Recovery of Function Following Neural Damage$354,836
R01 · FY2006 · NS · contact PI
Recovery of Function Following Neural Damage$363,375
R01 · FY2005 · NS
Recovery of Function Following Neural Damage$363,375
R01 · FY2004 · NS
Recovery of Function Following Neural Damage$363,375
R01 · FY2003 · NS
EXPERIENCE AND NEUROCHEMISTRY OF THE SYNAPSE$352,558
R01 · FY2002 · NS
RECOVERY OF FUNCTION FOLLOWING NEURAL DAMAGE$45,900
R01 · FY2002 · NS
EXPERIENCE AND NEUROCHEMISTRY OF THE SYNAPSE$345,433
R01 · FY2001 · NS
RECOVERY OF FUNCTION FOLLOWING NEURAL DAMAGE$339,317
R01 · FY2001 · NS
EXPERIENCE AND NEUROCHEMISTRY OF THE SYNAPSE$336,195
R01 · FY2000 · NS
RECOVERY OF FUNCTION FOLLOWING NEURAL DAMAGE$329,437
R01 · FY2000 · NS